Contact Person : Keystone Symposia; Last Date for the submission of abstract : 23/12/2008; Description : To discuss the opportunities and liabilities of
targeting the PI 3-kinase pathway in disease,
drawing on human pathophysiology and genetics,
mouse models and preclinical data with new PI 3-
kinase inhibitors.